|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
|
HUP0104987A3
(en)
|
1998-12-18 |
2002-09-30 |
Axys Pharmaceuticals Inc South |
Benzimidazole or indole derivatives protease inhibitors, and pharmaceutical compositions containing them
|
|
CA2387351C
(en)
|
1999-10-19 |
2009-09-08 |
Merck & Co., Inc. |
Indole derivatives as tyrosine kinase inhibitors
|
|
WO2003051847A1
(en)
|
2001-12-19 |
2003-06-26 |
Smithkline Beecham P.L.C. |
(1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors
|
|
DK1474425T3
(da)
|
2002-01-07 |
2006-09-25 |
Eisai Co Ltd |
Deazapuriner og anvendelser deraf
|
|
DE10209520A1
(de)
*
|
2002-03-04 |
2003-09-25 |
4Sc Ag |
Neue Modulatoren von Kaliumkanälen
|
|
FR2836915B1
(fr)
*
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
MXPA05013922A
(es)
|
2003-06-20 |
2006-02-24 |
Coley Pharm Group Inc |
Antagonistas de receptor tipo toll de molecula pequena.
|
|
WO2007115306A2
(en)
|
2006-04-04 |
2007-10-11 |
Myriad Genetics, Inc. |
Compounds for diseases and disorders
|
|
US20060235037A1
(en)
|
2005-04-15 |
2006-10-19 |
Purandare Ashok V |
Heterocyclic inhibitors of protein arginine methyl transferases
|
|
DK1899333T3
(da)
*
|
2005-06-27 |
2009-06-15 |
Sanofi Aventis |
Pyrazolopyridinderivater som inhibitorer af beta-adrenerg receptor-kinase 1
|
|
DE102006033109A1
(de)
|
2006-07-18 |
2008-01-31 |
Grünenthal GmbH |
Substituierte Heteroaryl-Derivate
|
|
US8027888B2
(en)
|
2006-08-31 |
2011-09-27 |
Experian Interactive Innovation Center, Llc |
Online credit card prescreen systems and methods
|
|
WO2008065198A1
(en)
|
2006-12-01 |
2008-06-05 |
Galapagos N.V. |
Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases
|
|
WO2008152471A1
(en)
|
2007-06-12 |
2008-12-18 |
Coley Pharmaceutical Group, Inc. |
Quinazoline derivative useful as toll-like receptor antagonist
|
|
WO2009030996A1
(en)
|
2007-09-05 |
2009-03-12 |
Coley Pharmaceutical Group, Inc. |
Triazole compounds as toll-like receptor (tlr) agonists
|
|
EP2205085A1
(en)
|
2007-09-25 |
2010-07-14 |
Merck Sharp & Dohme Corp. |
2-aryl or heteroaryl indole derivatives
|
|
US20110201599A1
(en)
|
2008-07-03 |
2011-08-18 |
Exelixis, Inc. |
CDK Modulators
|
|
US8354400B2
(en)
|
2008-09-26 |
2013-01-15 |
Eisai R&D Co., Ltd. |
Benzoxazole compounds and methods of use
|
|
CA2738929A1
(en)
|
2008-10-17 |
2010-04-22 |
Boehringer Ingelheim International Gmbh |
Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
|
|
TWI462920B
(zh)
|
2009-06-26 |
2014-12-01 |
葛萊伯格有限公司 |
用於治療退化性及發炎疾病之新穎化合物
|
|
NO2453895T3
(https=)
|
2009-07-16 |
2018-10-20 |
|
|
|
BR112012006630A2
(pt)
|
2009-09-24 |
2016-05-03 |
Hoffmann La Roche |
derivados em indol como moduladores dos canais de cálcio ativados para liberação de cálcio (crac)
|
|
US20110098311A1
(en)
|
2009-10-22 |
2011-04-28 |
Vertex Pharmaceuticals Incorported |
Compositions for treatment of cystic fibrosis and other chronic diseases
|
|
WO2012054862A2
(en)
|
2010-10-21 |
2012-04-26 |
The Brigham And Women's Hospital, Inc. |
Agents, compositions, and methods for treating pruritis and related skin conditions
|
|
DK2663555T3
(en)
|
2011-01-12 |
2017-03-27 |
Ventirx Pharmaceuticals Inc |
SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS
|
|
EP3208263A1
(en)
|
2011-01-12 |
2017-08-23 |
VentiRx Pharmaceuticals, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
|
WO2012167053A1
(en)
|
2011-06-01 |
2012-12-06 |
Janus Biotherapeutics, Inc. |
Novel immune system modulators
|
|
CA2837227C
(en)
|
2011-06-01 |
2022-05-10 |
Janus Biotherapeutics, Inc. |
Novel immune system modulators
|
|
CA2836487A1
(en)
|
2011-06-09 |
2012-12-13 |
Rhizen Pharmaceuticals Sa |
Novel compounds as modulators of gpr-119
|
|
TWI567079B
(zh)
|
2011-07-15 |
2017-01-21 |
健生醫藥公司 |
作為伽瑪分泌酶調節劑之新穎的經取代的吲哚衍生物
|
|
CA2850932A1
(en)
|
2011-10-04 |
2013-04-11 |
Janus Biotherapeutics, Inc. |
Novel imidazole quinoline-based immune system modulators
|
|
JP6184423B2
(ja)
|
2012-05-18 |
2017-08-23 |
大日本住友製薬株式会社 |
カルボン酸化合物
|
|
JO3407B1
(ar)
|
2012-05-31 |
2019-10-20 |
Eisai R&D Man Co Ltd |
مركبات رباعي هيدرو بيرازولو بيريميدين
|
|
WO2014025114A1
(ko)
|
2012-08-10 |
2014-02-13 |
주식회사 두산 |
유기 발광 화합물 및 이를 이용한 유기 전계 발광 소자
|
|
EP2738172A1
(en)
|
2012-11-28 |
2014-06-04 |
Almirall, S.A. |
New bicyclic compounds as crac channel modulators
|
|
SG10202103278TA
(en)
|
2013-10-14 |
2021-04-29 |
Eisai R&D Man Co Ltd |
Selectively substituted quinoline compounds
|
|
EP3080124A1
(en)
|
2013-12-13 |
2016-10-19 |
Takeda Pharmaceutical Company Limited |
Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors
|
|
HRP20210927T1
(hr)
|
2014-08-15 |
2021-09-03 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Spojevi pirolopirimidina koje se koriste kao agonist tlr7
|
|
EP3183251A4
(en)
|
2014-08-22 |
2017-12-27 |
Janus Biotherapeutics, Inc. |
Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
|
|
KR102562866B1
(ko)
*
|
2014-11-14 |
2023-08-04 |
네르비아노 메디칼 사이언시스 에스.알.엘. |
단백질 키나아제 억제제로서의 6-아미노-7-바이사이클로-7-데아자-퓨린 유도체
|
|
US10071079B2
(en)
|
2016-06-29 |
2018-09-11 |
Bristol-Myers Squibb Company |
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
|
|
MX391344B
(es)
|
2016-07-30 |
2025-03-21 |
Bristol Myers Squibb Co |
Compuestos indol sustituidos con dimetoxifenilo como inhibidores de receptores tipo toll 7, 8 o 9 (tlr7, tlr8 o tlr9).
|
|
KR102519535B1
(ko)
*
|
2016-09-09 |
2023-04-06 |
브리스톨-마이어스 스큅 컴퍼니 |
피리딜 치환된 인돌 화합물
|
|
BR112020012084A2
(pt)
|
2017-12-19 |
2020-11-24 |
Bristol-Myers Squibb Company |
compostos de indol substituído úteis como inibidores de tlr
|